| 1 |
35597399 | Study of the metabolic stability profiles of perampanel, rufinamide and stiripentol and prediction of drug interactions using HepaRG cells as an in vitro human model. | 2022 Aug |
1 |
| 2 |
32888296 | Quantification of the Plasma Concentrations of Perampanel Using High-Performance Liquid Chromatography and Effects of the CYP3A4*1G Polymorphism in Japanese Patients. | 2020 Oct 26 |
1 |
| 3 |
33171342 | Pharmacokinetics, tolerability, and clinical effectiveness of perampanel in Japanese patients with epilepsy. | 2020 Dec |
2 |
| 4 |
30580179 | Potential protein-binding displacement interactions with perampanel: An in vitro analysis. | 2019 Jan |
1 |
| 5 |
29171002 | Pharmacokinetic/pharmacodynamic analysis of adjunctive perampanel in subjects with partial-onset seizures. | 2018 Apr |
1 |
| 6 |
28535410 | Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters. | 2017 Aug |
1 |
| 7 |
28703720 | Therapeutic Drug Monitoring for Perampanel in Japanese Epilepsy Patients: Influence of Concomitant Antiepileptic Drugs. | 2017 Aug |
1 |
| 8 |
25495693 | The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist. | 2015 Jan |
1 |
| 9 |
25878177 | Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsy. | 2015 May 12 |
2 |
| 10 |
24785428 | The practical impact of altered dosing on perampanel plasma concentrations: pharmacokinetic modeling from clinical studies. | 2014 Jun |
1 |
| 11 |
23480152 | Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. | 2013 |
1 |